166 related articles for article (PubMed ID: 34102297)
1. Quality of Life Is Independently Associated With Neurocognitive Function in Patients With Brain Tumors: Analysis of a Prospective Clinical Trial.
Salans M; Tibbs MD; Huynh-Le MP; Yip A; Tringale K; Karunamuni R; Xu R; Reyes A; Macari AC; Pan-Weisz T; McDonald CR; Hattangadi-Gluth JA
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):754-763. PubMed ID: 34102297
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Analysis of Depression and Anxiety Symptoms as Independent Predictors of Neurocognitive Function in Primary Brain Tumor Patients.
Tibbs MD; Huynh-Le MP; Reyes A; Macari AC; Karunamuni R; Tringale K; Burkeen J; Marshall D; Xu R; McDonald CR; Hattangadi-Gluth JA
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1229-1239. PubMed ID: 32634542
[TBL] [Abstract][Full Text] [Related]
3. Dose-Dependent Atrophy in Bilateral Amygdalae and Nuclei After Brain Radiation Therapy and Its Association With Mood and Memory Outcomes on a Longitudinal Clinical Trial.
Unnikrishnan S; Karunamuni R; Salans MA; Gudipati S; Qian AS; Yu J; Connor M; Huynh-Le MP; Tibbs MD; Hermann G; Reyes A; Stasenko A; Seibert TM; McDonald CR; Hattangadi-Gluth JA
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):834-845. PubMed ID: 37230430
[TBL] [Abstract][Full Text] [Related]
4. Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma.
Noll KR; Bradshaw ME; Weinberg JS; Wefel JS
Psychooncology; 2017 May; 26(5):617-624. PubMed ID: 26677053
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Imaging Biomarkers of Damage to Critical Memory Regions Are Associated With Post-Radiation Therapy Memory Performance in Brain Tumor Patients.
Tringale KR; Nguyen TT; Karunamuni R; Seibert T; Huynh-Le MP; Connor M; Moiseenko V; Gorman MK; Marshall A; Tibbs MD; Farid N; Simpson D; Sanghvi P; McDonald CR; Hattangadi-Gluth JA
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):773-783. PubMed ID: 31408667
[TBL] [Abstract][Full Text] [Related]
6. Factors Affecting the Baseline and Post-Treatment Scores on the Hopkins Verbal Learning Test-Revised Japanese Version before and after Whole-Brain Radiation Therapy.
Saito H; Tanaka K; Kanemoto A; Nakano T; Abe E; Aoyama H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827891
[TBL] [Abstract][Full Text] [Related]
7. Family Functioning Mediates the Association Between Neurocognitive Functioning and Health-Related Quality of Life in Young Adult Survivors of Childhood Brain Tumors.
Hocking MC; Hobbie WL; Deatrick JA; Hardie TL; Barakat LP
J Adolesc Young Adult Oncol; 2015 Mar; 4(1):18-25. PubMed ID: 25852971
[TBL] [Abstract][Full Text] [Related]
8. Atypical performance patterns on Delis-Kaplan Executive Functioning System Color-Word Interference Test: Cognitive switching and learning ability in older adults.
Berg JL; Swan NM; Banks SJ; Miller JB
J Clin Exp Neuropsychol; 2016 Sep; 38(7):745-51. PubMed ID: 27133973
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial.
Yang WC; Chen YF; Yang CC; Wu PF; Chan HM; Chen JL; Chen GY; Cheng JC; Kuo SH; Hsu FM
Neuro Oncol; 2021 Mar; 23(3):478-486. PubMed ID: 32789503
[TBL] [Abstract][Full Text] [Related]
10. Relationship between cognitive functioning, mood, and other patient factors on quality of life in metastatic brain cancer.
Marotta D; Tucker Z; Hayward EN; Gerstenecker A; Gammon M; Mason M; Willhelm G; Bae H; Triebel K
Psychooncology; 2020 Jul; 29(7):1174-1184. PubMed ID: 32364662
[TBL] [Abstract][Full Text] [Related]
11. Real Life Data on Patient-Reported Outcomes and Neuro-Cognitive Functioning of Lung Cancer Patients: The PRO-Long Study.
Van Der Weijst L; Surmont V; Schrauwen W; Lievens Y
Front Oncol; 2021; 11():685605. PubMed ID: 34222010
[TBL] [Abstract][Full Text] [Related]
12. A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer.
Gui C; Chintalapati N; Hales RK; Voong KR; Sair HI; Grimm J; Duhon M; Kleinberg LR; Vannorsdall TD; Redmond KJ
J Neurooncol; 2019 Sep; 144(2):351-358. PubMed ID: 31302830
[TBL] [Abstract][Full Text] [Related]
13. CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933.
Caine C; Deshmukh S; Gondi V; Mehta M; Tomé W; Corn BW; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Raben A; Shi W; Wendland M; Kachnic L
J Neurooncol; 2016 Jan; 126(2):327-36. PubMed ID: 26511494
[TBL] [Abstract][Full Text] [Related]
14. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.
Sun A; Bae K; Gore EM; Movsas B; Wong SJ; Meyers CA; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H
J Clin Oncol; 2011 Jan; 29(3):279-86. PubMed ID: 21135267
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive status in patients with newly-diagnosed brain tumors in good neurological condition: The impact of tumor type, volume, and location.
Hendrix P; Hans E; Griessenauer CJ; Simgen A; Oertel J; Karbach J
Clin Neurol Neurosurg; 2017 May; 156():55-62. PubMed ID: 28334687
[TBL] [Abstract][Full Text] [Related]
16. Cognition and Functional Capacity: An Initial Comparison of Veteran and Non-Veteran Older Adults.
Maye JE; Depp CA; Lee EE; Keller AV; Kim HC; Jeste DV; Twamley EW
Mil Med; 2024 May; ():. PubMed ID: 38739491
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.
Weller J; Tzaridis T; Mack F; Steinbach JP; Schlegel U; Hau P; Krex D; Grauer O; Goldbrunner R; Bähr O; Uhl M; Seidel C; Tabatabai G; Brehmer S; Bullinger L; Galldiks N; Schaub C; Kebir S; Stummer W; Simon M; Fimmers R; Coch C; Glas M; Herrlinger U; Schäfer N
Lancet Oncol; 2019 Oct; 20(10):1444-1453. PubMed ID: 31488360
[TBL] [Abstract][Full Text] [Related]
18. Association of Pretreatment Hippocampal Volume With Neurocognitive Function in Patients Treated With Hippocampal Avoidance Whole Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology/RTOG 0933.
Abraham CD; Pugh SL; Bovi JA; Gondi V; Mehta MP; Benzinger T; Owen CJ; Lo SS; Kundapur V; Brown PD; Sun AY; Howard SP; DeNittis AS; Robinson CG; Kachnic LA
Adv Radiat Oncol; 2022; 7(6):100859. PubMed ID: 36420209
[TBL] [Abstract][Full Text] [Related]
19. Neurological outcome and memory performance in patients with 10 or more brain metastases treated with frameless linear accelerator (LINAC)-based stereotactic radiosurgery.
Minniti G; Capone L; Nardiello B; El Gawhary R; Raza G; Scaringi C; Bianciardi F; Gentile P; Paolini S
J Neurooncol; 2020 May; 148(1):47-55. PubMed ID: 32100230
[TBL] [Abstract][Full Text] [Related]
20. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.
Mata IF; Leverenz JB; Weintraub D; Trojanowski JQ; Hurtig HI; Van Deerlin VM; Ritz B; Rausch R; Rhodes SL; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson AL; Espay AJ; Revilla FJ; Devoto J; Hu SC; Cholerton BA; Wan JY; Montine TJ; Edwards KL; Zabetian CP
JAMA Neurol; 2014 Nov; 71(11):1405-12. PubMed ID: 25178429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
